Fredun Pharmaceuticals Ltd — Updates, 09-07-2025: Company Update

Fredun Pharmaceuticals has received a certificate from its SEBI-registered Registrar and Share Transfer Agent confirming that all share certificates submitted for dematerialisation during the quarter ended June 30, 2025, were duly processed. The shares have been accepted or rejected as appropriate, and the physical certificates were cancelled after verification. This ensures shareholders’ securities are properly recorded in electronic form, supporting smoother trading and ownership tracking for investors.